洞察免疫瘤学药物开发格局,重点关注骨转移
Tiina E Kähkönen1, Jussi M Halleen1, Gary MacRitchie2
1OncoBone Ltd, Oulu, Finland.
Frontiers in immunology
|July 21, 2023
概括
针对骨转移的新型免疫疗法正在出现,重点是瘤微环境和骨免疫瘤学 (OIO). 研究确定了24种正在开发的免疫疗法,用于乳腺癌和前列腺癌骨转移.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 骨生物学 骨生物学 骨生物学
背景情况:
- 骨转移是乳腺癌,前列腺癌和其他癌症的重大挑战,导致高死亡率和生活质量差.
- 目前的免疫疗法对骨转移的疗效有限,这凸显了需要新的治疗策略.
- 骨中的瘤微环境在骨转移的进展中发挥着关键作用,涉及瘤细胞,免疫细胞和骨细胞之间的复杂相互作用.
研究的目的:
- 审查目前免疫瘤学药物开发的骨转移现状.
- 确定针对独特的骨瘤微环境的新型免疫疗法.
- 探索新兴的骨质免疫瘤学 (OIO) 领域的治疗机会.
主要方法:
- 利用了第一瘤学数据库,这是癌症药物开发资源.
- 已确定乳腺癌和前列腺癌骨转移的临床前或临床开发中的免疫疗法.
- 专注于评估对骨转移的影响的疗法.
主要成果:
- 确定了24种用于骨转移的临床前或临床发展的免疫疗法.
- 这些疗法针对骨瘤微环境的各个方面.
- 该研究强调了骨质免疫瘤学日益增长的兴趣和发展.
结论:
- 骨瘤微环境为骨转移提供了许多潜在的治疗点.
- 新的骨免疫瘤学 (OIO) 概念为理解和准这些相互作用提供了一个框架.
- 预计基于OIO的治疗方法的进一步发展将为骨转移带来新的治疗机会.
更多相关视频
相关概念视频
Tumor Immunotherapy
560
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
560
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K


